New CAR T-cell Therapy Seen to Induce Lasting Remission in Advanced Multiple Myeloma Patients – Myeloma Research News
|
New CAR T-cell Therapy Seen to Induce Lasting Remission in Advanced Multiple Myeloma Patients
Myeloma Research News An ongoing Phase 1 trial testing a novel CAR T-cell therapy has shown promising results in relapsed or treatment-resistant (refractory) multiple myeloma patients. The new anti-BCMA therapy, called LCAR-B38M, induced tumor responses in all 35 enrolled … |
